Choksi Laboratories Ltd Financials
Company Logo

Choksi Laboratories Ltd Financial Statement

Choksi Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue10.74
Operating Expense7.90
Net Profit0.42
Net Profit Margin3.91
Earning Per Share0.60
EBIDTA2.64
Effective Tax RateTBA

Choksi Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual36.70
Operating Expenses Annual26.48
Operating Profit Annual10.38
Interest Annual3.01
Depreciation5.71
Net Profit Annual1.11
Tax Annual0.55

Choksi Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.34
Cash Flow from Operations11.55
Cash Flow from Investing-6.65
Cash Flow from Financing-4.58
Cash Flow at the End0.66

Choksi Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)28.45
PBIT Margin (%)12.89
PBT Margin (%)8.69
Net PROFIT Margin (%)3.02
Return On Networth / Equity (%)5.12
Return On Networth /Employed (%)8.58
Return On Assets (%)2.03
Total Debt / Equity (X)1.46
Asset Turnover Ratio (%)0.67

Choksi Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual43.75
Total Current Assets Annual14.57
Non Current Assets Annual47.38
Total Shareholders Funds Annual22.21
Total Assets Annual61.95

Choksi Laboratories Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 5, 2024, Choksi Laboratories Ltd has a market capitalization of 29.52 Cr. Value Research classifies it as a Micro-Cap company.
No, Choksi Laboratories Ltd is not debt-free with a debt-to-equity ratio of 1.34.
In FY 2023 , Choksi Laboratories Ltd recorded a total revenue of approximately 36.70 Cr marking a significant milestone in the company's financial performance.
Choksi Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.1% annually, respectively..
Choksi Laboratories Ltd's current PE ratio is 26.59.
Choksi Laboratories Ltd's ROCE averaged 8.2% from the FY ending March 2022 to 2024, with a median of 8.8%. It peaked at 9.3% in March 2023, reflecting strong capital efficiency over the period..
Choksi Laboratories Ltd's latest EBIT is Rs. 4.67 Cr, surpassing the average EBIT of Rs. 5.15 Cr over the 5 years..